BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16942658)

  • 1. Hepatitis delta virus super-infection in a co-infected patient with the human immunodeficiency virus type 1 and a surface antigen-negative hepatitis B virus variant.
    Gordien E; Bouhassoune K; Calboreanu A; Alloui C; Rico-Garcia M; Salmon-Céron D; Legal F; Dény P; Sogni P; Podevin P
    Int J STD AIDS; 2006 Sep; 17(9):635-8. PubMed ID: 16942658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wild type and YMDD variant of hepatitis B virus: no difference in viral kinetics on lamivudine/tenofovir therapy in HIV-HBV co-infected patients.
    de Vries-Sluijs TE; van der Eijk AA; Hansen BE; Osterhaus AD; de Man RA; van der Ende ME
    J Clin Virol; 2006 May; 36(1):60-3. PubMed ID: 16418013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
    Quiros-Roldan E; Calabresi A; Lapadula G; Tirelli V; Costarelli S; Cologni G; Zaltron S; Puoti M; Carosi G; Torti C
    Antivir Ther; 2008; 13(3):341-8. PubMed ID: 18572746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
    Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM
    J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
    Selabe SG; Lukhwareni A; Song E; Leeuw YG; Burnett RJ; Mphahlele MJ
    J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.
    Jain MK; Comanor L; White C; Kipnis P; Elkin C; Leung K; Ocampo A; Attar N; Keiser P; Lee WM
    J Viral Hepat; 2007 Mar; 14(3):176-82. PubMed ID: 17305883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ninety-six-week efficacy of combination therapy with lamivudine and tenofovir in patients coinfected with HIV-1 and wild-type hepatitis B virus.
    Bani-Sadr F; Palmer P; Scieux C; Molina JM
    Clin Infect Dis; 2004 Oct; 39(7):1062-4. PubMed ID: 15472862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversibility of cirrhosis in HIV/HBV coinfection.
    Mallet VO; Dhalluin-Venier V; Verkarre V; Correas JM; Chaix ML; Viard JP; Pol S
    Antivir Ther; 2007; 12(2):279-83. PubMed ID: 17503671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir.
    Matthews GV; Cooper DA; Dore GJ
    Antivir Ther; 2007; 12(1):119-22. PubMed ID: 17503756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of HDV, HBV and HIV in chronic B and D infections and in reactivation of chronic D infection.
    Govindarajan S; Cassidy WM; Valinluck B; Redeker AG
    Prog Clin Biol Res; 1991; 364():207-10. PubMed ID: 2020697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient.
    Amini-Bavil-Olyaee S; Sheldon J; Lutz T; Trautwein C; Tacke F
    AIDS; 2009 Jan; 23(2):268-72. PubMed ID: 19098499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-HBV vaccine escape mutant infection with loss of HBV surface antibody and persistent HBV viremia on tenofovir/emtricitabine without antiviral resistance.
    Schirmer P; Winters M; Holodniy M
    J Clin Virol; 2011 Nov; 52(3):261-4. PubMed ID: 21840252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection.
    Schmutz G; Nelson M; Lutz T; Sheldon J; Bruno R; von Boemmel F; Hoffmann C; Rockstroh J; Stoehr A; Wolf E; Soriano V; Berger F; Berg T; Carlebach A; Schwarze-Zander C; Schürmann D; Jaeger H; Mauss S
    AIDS; 2006 Oct; 20(15):1951-4. PubMed ID: 16988516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).
    Diop-Ndiaye H; Touré-Kane C; Etard JF; Lô G; Diaw P; Ngom-Gueye NF; Gueye PM; Ba-Fall K; Ndiaye I; Sow PS; Delaporte E; Mboup S
    J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced glomerular filtration rate but sustained virologic response in HIV/hepatitis B co-infected individuals on long-term tenofovir.
    Tan LK; Gilleece Y; Mandalia S; Murungi A; Grover D; Fisher M; Atkins M; Nelson M
    J Viral Hepat; 2009 Jul; 16(7):471-8. PubMed ID: 19457140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of wildtype and pre-C HBV variants in HBsAg/anti-HBe positive carriers with chronic hepatitis delta virus infection.
    Santantonio T; Jung MC; Monno L; Milella M; Iacovazzi T; Pastore G; Will H
    Prog Clin Biol Res; 1993; 382():235-42. PubMed ID: 8502687
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune reconstitution hepatitis in HIV and hepatitis B coinfection, despite lamivudine therapy as part of HAART.
    Drake A; Mijch A; Sasadeusz J
    Clin Infect Dis; 2004 Jul; 39(1):129-32. PubMed ID: 15206064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid improvement of liver function in a patient with HIV and hepatitis B coinfection treated with lamivudine and tenofovir.
    Lehmann C; Wyen C; Fätkenheuer G
    Infection; 2006 Aug; 34(4):234-5. PubMed ID: 16896585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
    Nübling CM; Chudy M; Volkers P; Löwer J
    Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.